Table 2.
Perioperative factors for patients undergoing percutaneous dilatational tracheostomy
| Perioperative factors | Value |
|---|---|
| Hemoglobin (g/dL) | 8.1±1.2 (6.2–13.9) |
| White blood cells (×109/L) | 19.5±20.8 (4.6–149.0) |
| Platelet count (×109/L) | 191.6±128.6 (8.7–750.0) |
| International normalized ratio | 1.5±0.3 (0.9–2.6) |
| Partial thromboplastin time (sec) | 55.2±19.6 (4.2–130.0) |
| Chronic kidney disease status | |
| Stage 1 | 16 (17.4) |
| Stage 2 | 21 (22.8) |
| Stage 3 | 38 (41.3) |
| Stage 4 | 14 (15.2) |
| Stage 5 | 3 (3.3) |
| Ejection fraction (%) | 47.7 (10.0–75.0) |
| Dual antiplatelet therapy | 19 (20.4) |
| Anticoagulation after 8 hours | 76 (81.7) |
| ECMO/LVAD | 21 (22.6) |
| ECMO O2 (mm Hg) (n=10) | 267.2±114.9 (120.0–471.0) |
Values are presented as mean±standard deviation (range), number (%), or mean (range). Laboratory values closest in time prior to the procedure were utilized.
ECMO, extracorporeal membrane oxygenation; LVAD, left ventricular assist device.